Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III: Comparison of the Efficacy and Safety of T2762 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

NCT02023268 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT02023268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III: Comparison of the Efficacy and Safety of T2762 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
Lead sponsor
Laboratoires Thea
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2013
Completion date
February 28, 2015
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome